Literature DB >> 24117236

The Fc receptor-like 3 gene polymorphisms and susceptibility to autoimmune diseases: an updated meta-analysis.

Yan Yang1, XiaoWei Su, Kui Zhang, Rong Zhou.   

Abstract

Previous studies have identified several single nucleotide polymorphisms (SNPs) of Fc receptor-like 3 (FCRL3), an excellent susceptibility gene, as predisposing factors for human autoimmune diseases (ADs). However, the results remain inconclusive. To assess the effect of four selected SNPs (rs7528684, rs11264799, rs945635 and rs3761959), we conducted a meta-analysis with 34 case-control studies. Summary odd ratios (ORs) and 95% confidence intervals (95% CIs) for the polymorphisms in FCRL3 and ADs risk were evaluated. Furthermore, this meta-analysis was performed by using allele comparisons, as well as stratified analyses by ethnicity and disease phenotypes under different genetic models. Our data showed that the TC, TT + TC genotypes of rs7528684 contributed to a lower risk of ADs, compared with the CC carriers (OR = 0.91, 95% CI = 0.85-0.97; OR = 0.91, 95% CI = 0.85-0.98). In comparison with rs7528684 TC genotype, the TT + CC carriers were significantly associated with higher ADs risk (OR = 1.03, 95% CI = 1.00-1.07). In terms of stratified analyses by ethnicity and disease phenotypes, there were significant associations of rs7528684 polymorphism both with ADs in Asians and Europeans, and with rheumatoid arthritis, Graves' disease, type-1 diabetes, and other ADs under different genetic models. Moreover, significant associations were also found to be correlated with ADs risk for the SNP rs11264799 in mixed subgroup, for rs945635 in Europeans, North Americans and mixed group, and for rs3761959 in North Americans. These findings indicate that the polymorphisms in FCRL3 may play a role in the pathogenesis of ADs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24117236     DOI: 10.3109/08916934.2013.835804

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  8 in total

Review 1.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 2.  Autoimmunity in 2013.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

3.  Correlation between single nucleotide polymorphism of FCRL-3 gene and Graves' disease in Han population of northern Anhui province, China.

Authors:  Guo-Xi Jin; Yu-Ye Zhou; Lei Yu; Ya-Xin Bi
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  FCRL3 gene polymorphisms confer autoimmunity risk for allergic rhinitis in a Chinese Han population.

Authors:  Zheng Gu; Su-Ling Hong; Xia Ke; Yang Shen; Xiao-Qiang Wang; Di Hu; Guo-Hua Hu; Hou-Yong Kang
Journal:  PLoS One       Date:  2015-01-16       Impact factor: 3.240

5.  Inflammation-Related Gene Polymorphisms Associated With Primary Immune Thrombocytopenia.

Authors:  Ju Li; Sai Ma; Linlin Shao; Chunhong Ma; Chengjiang Gao; Xiao-Hui Zhang; Ming Hou; Jun Peng
Journal:  Front Immunol       Date:  2017-06-28       Impact factor: 7.561

6.  Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms.

Authors:  Panagiotis Antiochos; Pedro Marques-Vidal; Julien Virzi; Sabrina Pagano; Nathalie Satta; Oliver Hartley; Fabrizio Montecucco; François Mach; Zoltán Kutalik; Gerard Waeber; Peter Vollenweider; Nicolas Vuilleumier
Journal:  Front Immunol       Date:  2017-04-18       Impact factor: 7.561

7.  Single Nucleotide Polymorphisms of FCRL3 in Iranian Patients with Behcet's Disease.

Authors:  Farhad Shahram; Javad Kazemi; Mahmoud Mahmoudi; Zohreh Jadali
Journal:  Iran J Public Health       Date:  2019-06       Impact factor: 1.429

8.  Genetic Polymorphisms of FCRL3, NLRP3 and IL2 are Associated with the Risk of Head and Neck Cancer in a Chinese Population.

Authors:  Yuhao Zhang; Dawei Sun
Journal:  Pharmgenomics Pers Med       Date:  2021-08-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.